The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Allopurinol Hypersensitivity Syndrome: A Review
Abstract
OBJECTIVE: To review the pathophysiology, pathology, and clinical findings of allopurinol hypersensitivity syndrome (AHS), an infrequent but life-threatening adverse effect of allopurinol therapy. DATA SOURCES: A MEDLINE search (key terms hepatitis, interstitial nephritis, severe hypersensitivity, severe toxicity, vasculitis, toxic epidermal necrolysis, Lyell's syndrome, erythema multiforme, and Stevens-Johnson syndrome) was used to identify cases reported in the literature through the end of 1990. STUDY SELECTION: All cases evaluated met Singer and Wallace's diagnostic criteria for AHS. DATA EXTRACTION: We extracted data from 101 cases of AHS reported in the literature. The following information, when available, was analyzed: (1) patient data (age, gender, medical history), (2) treatment data (daily dosage of allopurinol, duration of treatment, indications, concomitant medications, and (3) adverse-event data. DATA SYNTHESIS: Patients were mostly middle-aged men with hypertension and/or renal failure receiving excessive doses of allopurinol primarily for asymptomatic hyperuricemia. Cutaneous rash and fever were the most common clinical findings. CONCLUSIONS: Although the pathophysiologic pathway leading to the development of AHS is unknown, it probably involves an immunologic mechanism following allopurinol accumulation in patients with poor renal function. Our findings suggest that the accepted diagnostic criteria for AHS may be too broad, and we recommend the application of more restrictive criteria. There is no effective treatment for AHS. The use of allopurinol only for accepted indications and in dosages adjusted for a patient's renal function may be the only means of minimizing the incidence of AHS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hande, K. R., Noone, R. M., & Stone, W. J. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90743-5 · Cited by 680
Genetic Susceptibility to Toxic Epidermal Necrolysis
Roujeau, J. (1987) · Archives of Dermatology · doi:10.1001/archderm.123.9.1171 · Cited by 278
The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality
Singer, J. Z., & Wallace, S. L. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290111 · Cited by 245
Acute adverse reactions attributed to allopurinol in hospitalised patients.
McInnes, G. T., Lawson, D. H., & Jick, H. (1981) · Annals of the Rheumatic Diseases · doi:10.1136/ard.40.3.245 · Cited by 160
Severe allopurinol hypersensitivity. Association with thiazides and prior renal compromise
Young, J. L. (1974) · Archives of Internal Medicine · doi:10.1001/archinte.134.3.553 · Cited by 125
Severe Allopurinol Hypersensitivity
Young, J. L. (1974) · Archives of Internal Medicine · doi:10.1001/archinte.1974.00320210163026 · Cited by 100
Severe Hypersensitivity Reactions Associated With Allopurinol
Mills, R. M. (1971) · JAMA · doi:10.1001/jama.1971.03180310037007 · Cited by 84
Vasculitis with allopurinol therapy
Jarzobski, J. A., Ferry, J., Wombolt, D. G., Fitch, D. M., & Egan, J. D. (1970) · American Heart Journal · doi:10.1016/0002-8703(70)90401-1 · Cited by 75
PLASMA OXIPURINOL CONCENTRATIONS DURING ALLOPURINOL THERAPY
Emmerson, B. T., Gordon, R. B., CROSS, M., & Thomson, D. B. (1987) · Rheumatology · doi:10.1093/rheumatology/26.6.445 · Cited by 73
THE SPECTRUM OF HEPATOTOXICITY DUE TO DRUGS
Sherlock, S. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92144-6 · Cited by 68
Cited by
Khanna, D., Fitzgerald, J. D., Khanna, P. P., Bae, S., Singh, M. K., Neogi, T., Pillinger, M. H., Merill, J., Lee, S., Prakash, S., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21772 · Cited by 1,536
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
Hung, S.-I., Chung, W.-H., Liou, L.-B., Chu, C.-C., Lin, M., Huang, H.-P., Lin, Y.-L., Lan, J.-L., Yang, L.-C., Hong, H.-S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409500102 · Cited by 1,284
Pacher, P., Nivorozhkin, A., & Szabó, C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.6 · Cited by 1,218
Schumacher, H. R., Becker, M. A., Wortmann, R. L., MacDonald, P. A., Hunt, B., Streit, J., Lademacher, C., & Joseph‐Ridge, N. (2008) · Arthritis Care & Research · doi:10.1002/art.24209 · Cited by 638
Suzuki, Y., Inagi, R., Aono, T., Yamanishi, K., & Shiohara, T. (1998) · Archives of Dermatology · doi:10.1001/archderm.134.9.1108 · Cited by 349
Metadata
- Authors
- Arellano, F., & Sacristán, J. A.
- Venue
- Annals of Pharmacotherapy
- Publisher
- SAGE Publications
- Published
- 1993-03
- Volume
- 27
- Issue
- 3
- Pages
- 337-343
- ISSN
- 0012-6578 (ISSN-L)
- 1060-0280
- 1542-6270
- OpenAlex
- W2165447689
- Cited by
- 318
- References
- 19
- FWCI
- 0.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Allopurinol Hypersensitivity Syndrome: A Review. https://app.cochat.ai/papers/10.1177/106002809302700317
- The paper
- Arellano, F., & Sacristán, J. A. (1993). Allopurinol Hypersensitivity Syndrome: A Review. Annals of Pharmacotherapy. https://doi.org/10.1177/106002809302700317
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.